171 related articles for article (PubMed ID: 30381742)
1. Chicken novel leukocyte immunoglobulin-like receptor subfamilies B1 and B3 are transcriptional regulators of major histocompatibility complex class I genes and signaling pathways.
Truong AD; Hong Y; Lee J; Lee K; Tran HTT; Dang HV; Nguyen VK; Lillehoj HS; Hong YH
Asian-Australas J Anim Sci; 2019 May; 32(5):614-628. PubMed ID: 30381742
[TBL] [Abstract][Full Text] [Related]
2. Characterization and functional analyses of novel chicken leukocyte immunoglobulin-like receptor subfamily B members 4 and 5.
Truong AD; Hong Y; Tran HTT; Dang HV; Nguyen VK; Pham TT; Lillehoj HS; Hong YH
Poult Sci; 2019 Dec; 98(12):6989-7002. PubMed ID: 31376355
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification and characterisation of a novel chicken leukocyte immunoglobulin-like receptor A5.
Truong AD; Hong Y; Nguyen HT; Nguyen CT; Chu NT; Tran HTT; Dang HV; Lillehoj HS; Hong YH
Br Poult Sci; 2021 Feb; 62(1):68-80. PubMed ID: 32812773
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte Immunoglobulin-Like Receptors A2 and A6 are Expressed in Avian Macrophages and Modulate Cytokine Production by Activating Multiple Signaling Pathways.
Truong AD; Rengaraj D; Hong Y; Tran HTT; Dang HV; Nguyen VK; Lillehoj HS; Hong YH
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208630
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory leukocyte immunoglobulin-like receptors in cancer development.
Zhang F; Zheng J; Kang X; Deng M; Lu Z; Kim J; Zhang C
Sci China Life Sci; 2015 Dec; 58(12):1216-25. PubMed ID: 26566804
[TBL] [Abstract][Full Text] [Related]
6. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-dependent modulation of the expression of MHC class I and MHC class II genes in chicken HD11 cells.
Truong AD; Hong Y; Ly VD; Nguyen HT; Nguyen CT; Vu HT; Chu NT; Van Hoang T; Thanh Tran HT; Dang HV; Hong YH
Dev Comp Immunol; 2020 Sep; 110():103729. PubMed ID: 32387556
[TBL] [Abstract][Full Text] [Related]
9. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-34 Regulates Th1 and Th17 Cytokine Production by Activating Multiple Signaling Pathways through CSF-1R in Chicken Cell Lines.
Truong AD; Hong Y; Lee J; Lee K; Kil DY; Lillehoj HS; Hong YH
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874806
[TBL] [Abstract][Full Text] [Related]
11. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Barkal AA; Weiskopf K; Kao KS; Gordon SR; Rosental B; Yiu YY; George BM; Markovic M; Ring NG; Tsai JM; McKenna KM; Ho PY; Cheng RZ; Chen JY; Barkal LJ; Ring AM; Weissman IL; Maute RL
Nat Immunol; 2018 Jan; 19(1):76-84. PubMed ID: 29180808
[TBL] [Abstract][Full Text] [Related]
12. The AP-1 transcription factor JunD activates the leukocyte immunoglobulin-like receptor 1 distal promoter.
Davidson CL; Cameron LE; Burshtyn DN
Int Immunol; 2014 Jan; 26(1):21-33. PubMed ID: 24038602
[TBL] [Abstract][Full Text] [Related]
13. The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy.
Zhao J; Zhong S; Niu X; Jiang J; Zhang R; Li Q
Scand J Immunol; 2019 Nov; 90(5):e12804. PubMed ID: 31267559
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells.
Chen H; Chen Y; Deng M; John S; Gui X; Kansagra A; Chen W; Kim J; Lewis C; Wu G; Xie J; Zhang L; Huang R; Liu X; Arase H; Huang Y; Yu H; Luo W; Xia N; Zhang N; An Z; Zhang CC
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32771992
[TBL] [Abstract][Full Text] [Related]
15. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
Shiroishi M; Kuroki K; Tsumoto K; Yokota A; Sasaki T; Amano K; Shimojima T; Shirakihara Y; Rasubala L; van der Merwe PA; Kumagai I; Kohda D; Maenaka K
J Mol Biol; 2006 Jan; 355(2):237-48. PubMed ID: 16305801
[TBL] [Abstract][Full Text] [Related]
16. Characterization and functional analyses of a novel chicken CD8α variant X1 (CD8α1).
Truong AD; Ban J; Park B; Hong YH; Lillehoj HS
J Anim Sci; 2016 Jul; 94(7):2737-51. PubMed ID: 27482661
[TBL] [Abstract][Full Text] [Related]
17. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
[TBL] [Abstract][Full Text] [Related]
18. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
[TBL] [Abstract][Full Text] [Related]
19. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
